Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

One-Pot Synthesis of 1-Hydroxyacridones from para-Quinols and ortho-Methoxycarbonylaryl Isocyanates.

Wu J, Zhang J, Soto-Acosta R, Mao L, Lian J, Chen K, Pillon G, Zhang G, Geraghty RJ, Zheng S.

J Org Chem. 2020 Mar 20;85(6):4515-4524. doi: 10.1021/acs.joc.9b03307. Epub 2020 Feb 27.

PMID:
32070098
2.

Does chronic hyperglycaemia increase the risk of kidney stone disease? results from a systematic review and meta-analysis.

Geraghty R, Abdi A, Somani B, Cook P, Roderick P.

BMJ Open. 2020 Jan 19;10(1):e032094. doi: 10.1136/bmjopen-2019-032094.

3.

Evaluation of the economic burden of kidney stone disease in the UK: a retrospective cohort study with a mean follow-up of 19 years.

Geraghty RM, Cook P, Walker V, Somani BK.

BJU Int. 2020 Jan 8. doi: 10.1111/bju.14991. [Epub ahead of print]

PMID:
31916369
4.

Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review.

Prattley S, Geraghty R, Moore M, Somani BK.

Eur Urol Focus. 2019 Dec 2. pii: S2405-4569(19)30343-8. doi: 10.1016/j.euf.2019.11.002. [Epub ahead of print] Review.

PMID:
31806578
5.

Structure activity relationship, 6-modified purine riboside analogues to activate hSTING, stimulator of interferon genes.

Bonnac LF, Dreis CD, Geraghty RJ.

Bioorg Med Chem Lett. 2020 Jan 15;30(2):126819. doi: 10.1016/j.bmcl.2019.126819. Epub 2019 Nov 12.

PMID:
31780305
6.

The industrial revolution for the management of benign prostate obstruction: worldwide publication trends for surgical and medical therapies over the past two decades.

Nettleton J, Jones P, Pietropaolo A, Geraghty R, Rai B, Drake M, Dragos L, Veneziano D, Somani BK.

Cent European J Urol. 2019;72(2):149-155. doi: 10.5173/ceju.2019.1876. Epub 2019 Apr 26. Review.

7.

Role of pelvicalyceal anatomy in the outcomes of retrograde intrarenal surgery (RIRS) for lower pole stones: outcomes with a systematic review of literature.

Karim SS, Hanna L, Geraghty R, Somani BK.

Urolithiasis. 2019 Aug 1. doi: 10.1007/s00240-019-01150-0. [Epub ahead of print]

PMID:
31372691
8.

Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period.

Lima A, Reeves T, Geraghty R, Pietropaolo A, Whitehurst L, Somani BK.

World J Urol. 2019 Jul 24. doi: 10.1007/s00345-019-02878-5. [Epub ahead of print]

PMID:
31342247
9.

Predictors and Results of Negative Ureteroscopy for Treatment of Consecutive Ureteric Stones Done as a Primary Procedure: Prospective Outcomes from a University Hospital.

Prattley S, Rice P, Pietropaolo A, Geraghty R, Babawale O, Somani BK.

Urol Int. 2019;103(2):143-148. doi: 10.1159/000501658. Epub 2019 Jul 10.

PMID:
31291641
10.

Trends in surgical and ablative treatment of localised renal cell carcinoma: A review of publication trends over 16 years (2000-2015).

Pietropaolo A, Jones P, Aboumarzouk OM, Rai BP, Lockyer CRW, Hayes MC, Geraghty R, Bhatnagar A, Somani BK.

Arab J Urol. 2019 May 15;17(2):120-124. doi: 10.1080/2090598X.2019.1590516. eCollection 2019. Review.

11.

Nephrolithiasis in the Obese Patient.

Kelly C, Geraghty RM, Somani BK.

Curr Urol Rep. 2019 May 18;20(7):36. doi: 10.1007/s11934-019-0898-0. Review.

PMID:
31104149
12.

Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme.

McCarthy AJ, O'Reilly SM, Shanley J, Geraghty R, Ryan EJ, Cullen G, Sheahan K.

Gastroenterol Res Pract. 2019 Feb 6;2019:1592306. doi: 10.1155/2019/1592306. eCollection 2019.

13.

Simultaneous Bilateral Endoscopic Surgery (SBES) for Bilateral Urolithiasis: the Future? Evidence from a Systematic Review.

Geraghty RM, Jones P, Somani BK.

Curr Urol Rep. 2019 Feb 21;20(3):15. doi: 10.1007/s11934-019-0877-5.

PMID:
30790070
14.

Outcomes of European Basic Laparoscopic Urological Skills (EBLUS) Examinations: Results from European School of Urology (ESU) and EAU Section of Uro-Technology (ESUT) over 6 Years (2013-2018).

Somani BK, Van Cleynenbreugel B, Gözen AS, Skolarikos A, Wagner C, Beatty J, Barmoshe S, Gaya Sopena JM, Kalogeropoulos T, Faba OR, Salas RS, Schmidt M, Siena G, Pini G, Palou J, Geraghty R, Veneziano D.

Eur Urol Focus. 2019 Jan 17. pii: S2405-4569(19)30007-0. doi: 10.1016/j.euf.2019.01.007. [Epub ahead of print]

PMID:
30661943
15.

Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer.

Ryan ÉJ, Creavin B, Khaw YL, Kelly ME, Mohan HM, Geraghty R, Ryan EJ, Kennelly R, Hanly A, Martin ST, Fennelly D, McDermott R, Gibbons D, O'Connell PR, Sheahan K, Winter DC.

BJS Open. 2018 Jul 24;2(6):456-463. doi: 10.1002/bjs5.91. eCollection 2018 Dec.

16.

Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia.

Westwood J, Geraghty R, Jones P, Rai BP, Somani BK.

Ther Adv Urol. 2018 Aug 12;10(11):327-333. doi: 10.1177/1756287218793084. eCollection 2018 Nov. Review.

17.

FRET-based assay using a three-way junction DNA substrate to identify inhibitors of human cytomegalovirus pUL89 endonuclease activity.

Wang Y, Geraghty RJ.

Eur J Pharm Sci. 2019 Jan 15;127:29-37. doi: 10.1016/j.ejps.2018.10.016. Epub 2018 Oct 17.

PMID:
30342172
18.

Outcomes of Elective Ureteroscopy for Ureteric Stones in Patients with Prior Urosepsis and Emergency Drainage: Prospective Study over 5 yr from a Tertiary Endourology Centre.

Pietropaolo A, Hendry J, Kyriakides R, Geraghty R, Jones P, Aboumarzouk O, Somani BK.

Eur Urol Focus. 2020 Jan 15;6(1):151-156. doi: 10.1016/j.euf.2018.09.001. Epub 2018 Sep 13.

PMID:
30219711
19.

Hydroxypyridonecarboxylic Acids as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.

Kankanala J, Wang Y, Geraghty RJ, Wang Z.

ChemMedChem. 2018 Aug 20;13(16):1658-1663. doi: 10.1002/cmdc.201800283. Epub 2018 Jul 20.

PMID:
29968426
20.

Ureteroscopy is more cost effective than shock wave lithotripsy for stone treatment: systematic review and meta-analysis.

Geraghty RM, Jones P, Herrmann TRW, Aboumarzouk O, Somani BK.

World J Urol. 2018 Nov;36(11):1783-1793. doi: 10.1007/s00345-018-2320-9. Epub 2018 May 5.

21.

Efficacy and Safety of Ureteroscopy for Stone Disease in a Solitary Kidney: Findings From a Systematic Review.

Pietropaolo A, Jones P, Whitehurst L, Rai BP, Geraghty R, Somani BK.

Urology. 2018 Sep;119:17-22. doi: 10.1016/j.urology.2018.03.043. Epub 2018 Apr 24.

PMID:
29702154
22.

Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.

Qiu L, Patterson SE, Bonnac LF, Geraghty RJ.

PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006421. doi: 10.1371/journal.pntd.0006421. eCollection 2018 Apr.

23.

Safety and Efficacy of Day-case Percutaneous Nephrolithotomy: A Systematic Review from European Society of Uro-technology.

Jones P, Bennett G, Dosis A, Pietropaolo A, Geraghty R, Aboumarzouk O, Skolarikos A, Somani BK.

Eur Urol Focus. 2019 Nov;5(6):1127-1134. doi: 10.1016/j.euf.2018.04.002. Epub 2018 Apr 12. Review.

PMID:
29657068
24.

The European Urology Residents Education Programme Hands-on Training Format: 4 Years of Hands-on Training Improvements from the European School of Urology.

Somani BK, Van Cleynenbreugel B, Gozen A, Palou J, Barmoshe S, Biyani S, Gaya JM, Hellawell G, Pini G, Oscar FR, Sanchez Salas R, Macek P, Skolarikos A, Wagner C, Eret V, Haensel S, Siena G, Schmidt M, Klitsch M, Vesely S, Ploumidis A, Proietti S, Kamphuis G, Tokas T, Geraghty R, Veneziano D.

Eur Urol Focus. 2019 Nov;5(6):1152-1156. doi: 10.1016/j.euf.2018.03.002. Epub 2018 Mar 14.

PMID:
29550077
25.

Ureteroscopy and stone treatment in the elderly (≥70 years): prospective outcomes over 5- years with a review of literature.

Prattley S, Voss J, Cheung S, Geraghty R, Jones P, Somani BK.

Int Braz J Urol. 2018 Jul-Aug;44(4):750-757. doi: 10.1590/S1677-5538.IBJU.2017.0516. Review.

26.

Metal-chelating 3-hydroxypyrimidine-2,4-diones inhibit human cytomegalovirus pUL89 endonuclease activity and virus replication.

Wang Y, Tang J, Wang Z, Geraghty RJ.

Antiviral Res. 2018 Apr;152:10-17. doi: 10.1016/j.antiviral.2018.01.015. Epub 2018 Feb 6.

PMID:
29425830
27.

Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens.

O'Brien O, Ryan É, Creavin B, Kelly ME, Mohan HM, Geraghty R, Winter DC, Sheahan K.

J Clin Pathol. 2018 Jul;71(7):631-636. doi: 10.1136/jclinpath-2017-204946. Epub 2018 Feb 1.

PMID:
29419411
28.

Successful ureteroscopy for kidney stone disease leads to resolution of urinary tract infections: Prospective outcomes with a 12-month follow-up.

Oliver R, Ghosh A, Geraghty R, Moore S, Somani BK.

Cent European J Urol. 2017;70(4):418-423. doi: 10.5173/ceju.2017.1549. Epub 2017 Nov 7.

29.

Prescription of antihypertensive medication at discharge influences survival following stroke.

Andrew NE, Kim J, Thrift AG, Kilkenny MF, Lannin NA, Anderson CS, Donnan GA, Hill K, Middleton S, Levi C, Faux S, Grimley R, Gange N, Geraghty R, Ermel S, Cadilhac DA; Australian Stroke Clinical Registry Consortium.

Neurology. 2018 Feb 27;90(9):e745-e753. doi: 10.1212/WNL.0000000000005023. Epub 2018 Jan 31.

PMID:
29386279
30.

Effect of Music on Outpatient Urological Procedures: A Systematic Review and Meta-Analysis from the European Association of Urology Section of Uro-Technology.

Kyriakides R, Jones P, Geraghty R, Skolarikos A, Liatsikos E, Traxer O, Pietropaolo A, Somani BK.

J Urol. 2018 May;199(5):1319-1327. doi: 10.1016/j.juro.2017.11.117. Epub 2017 Dec 7.

PMID:
29225059
31.

Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.

Ryan É, Khaw YL, Creavin B, Geraghty R, Ryan EJ, Gibbons D, Hanly A, Martin ST, O'Connell PR, Winter DC, Sheahan K.

Am J Surg Pathol. 2018 Jan;42(1):60-68. doi: 10.1097/PAS.0000000000000931.

PMID:
29112018
32.

Evidence for plical support of the patella.

Geraghty RM, Spear M.

J Anat. 2017 Nov;231(5):698-707. doi: 10.1111/joa.12662. Epub 2017 Jul 18.

33.

Trends of 'urolithiasis: interventions, simulation, and laser technology' over the last 16 years (2000-2015) as published in the literature (PubMed): a systematic review from European section of Uro-technology (ESUT).

Pietropaolo A, Proietti S, Geraghty R, Skolarikos A, Papatsoris A, Liatsikos E, Somani BK.

World J Urol. 2017 Nov;35(11):1651-1658. doi: 10.1007/s00345-017-2055-z. Epub 2017 Jun 7. Review.

34.

Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.

O'Kane GM, Ryan É, McVeigh TP, Creavin B, Hyland JM, O'Donoghue DP, Keegan D, Geraghty R, Flannery D, Nolan C, Donovan E, Mehigan BJ, McCormick P, Muldoon C, Farrell M, Shields C, Mulligan N, Kennedy MJ, Green AJ, Winter DC, MacMathuna P, Sheahan K, Gallagher DJ.

Cancer Med. 2017 Jun;6(6):1465-1472. doi: 10.1002/cam4.1025. Epub 2017 May 3.

35.

Worldwide Impact of Warmer Seasons on the Incidence of Renal Colic and Kidney Stone Disease: Evidence from a Systematic Review of Literature.

Geraghty RM, Proietti S, Traxer O, Archer M, Somani BK.

J Endourol. 2017 Aug;31(8):729-735. doi: 10.1089/end.2017.0123. Epub 2017 May 1. Review.

PMID:
28338351
36.
37.

Worldwide Trends of Urinary Stone Disease Treatment Over the Last Two Decades: A Systematic Review.

Geraghty RM, Jones P, Somani BK.

J Endourol. 2017 Jun;31(6):547-556. doi: 10.1089/end.2016.0895. Review.

PMID:
28095709
38.

A fluorescence-based high-throughput assay to identify inhibitors of tyrosylprotein sulfotransferase activity.

Zhou W, Wang Y, Xie J, Geraghty RJ.

Biochem Biophys Res Commun. 2017 Jan 22;482(4):1207-1212. doi: 10.1016/j.bbrc.2016.12.013. Epub 2016 Dec 5.

PMID:
27923653
39.

Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.

Wang Y, Mao L, Kankanala J, Wang Z, Geraghty RJ.

J Virol. 2017 Jan 18;91(3). pii: e02152-16. doi: 10.1128/JVI.02152-16. Print 2017 Feb 1.

40.

Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.

Mohan HM, Ryan E, Balasubramanian I, Kennelly R, Geraghty R, Sclafani F, Fennelly D, McDermott R, Ryan EJ, O'Donoghue D, Hyland JM, Martin ST, O'Connell PR, Gibbons D, Winter D, Sheahan K.

Eur J Surg Oncol. 2016 Nov;42(11):1680-1686. doi: 10.1016/j.ejso.2016.05.013. Epub 2016 Jun 22.

PMID:
27370895
41.
42.

Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4(+) T Cells within Colorectal Tumors despite the Presence of Elevated CD39(+) T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1.

Dunne MR, Ryan C, Nolan B, Tosetto M, Geraghty R, Winter DC, O'Connell PR, Hyland JM, Doherty GA, Sheahan K, Ryan EJ, Fletcher JM.

Front Oncol. 2016 Mar 7;6:50. doi: 10.3389/fonc.2016.00050. eCollection 2016.

43.

Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.

Ai T, Qiu L, Xie J, Geraghty RJ, Chen L.

Bioorg Med Chem. 2016 Feb 15;24(4):686-92. doi: 10.1016/j.bmc.2015.12.035. Epub 2015 Dec 23.

PMID:
26753813
44.

Evidence for Ureterorenoscopy and Laser Fragmentation (URSL) for Large Renal Stones in the Modern Era.

Geraghty R, Abourmarzouk O, Rai B, Biyani CS, Rukin NJ, Somani BK.

Curr Urol Rep. 2015 Aug;16(8):54. doi: 10.1007/s11934-015-0529-3. Review.

PMID:
26077357
45.

5'-Silylated 3'-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus.

Vernekar SK, Qiu L, Zhang J, Kankanala J, Li H, Geraghty RJ, Wang Z.

J Med Chem. 2015 May 14;58(9):4016-28. doi: 10.1021/acs.jmedchem.5b00327. Epub 2015 May 4.

46.
47.

Hydroxamic acids block replication of hepatitis C virus.

Ai T, Xu Y, Qiu L, Geraghty RJ, Chen L.

J Med Chem. 2015 Jan 22;58(2):785-800. doi: 10.1021/jm501330g. Epub 2014 Dec 19.

PMID:
25490700
48.

Management of pediatric skin-graft donor sites: a randomized controlled trial of three wound care products.

Brenner M, Hilliard C, Peel G, Crispino G, Geraghty R, OʼCallaghan G.

J Burn Care Res. 2015 Jan-Feb;36(1):159-66. doi: 10.1097/BCR.0000000000000161.

PMID:
25185932
49.

Guidelines for the use of cell lines in biomedical research.

Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, Lovell-Badge R, Masters JR, Meredith J, Stacey GN, Thraves P, Vias M; Cancer Research UK.

Br J Cancer. 2014 Sep 9;111(6):1021-46. doi: 10.1038/bjc.2014.166. Epub 2014 Aug 12.

50.

Fluorescent peptide sensors for tyrosylprotein sulfotransferase activity.

Zhou W, Duckworth BP, Geraghty RJ.

Anal Biochem. 2014 Sep 15;461:1-6. doi: 10.1016/j.ab.2014.05.025. Epub 2014 Jun 5.

PMID:
24909447

Supplemental Content

Loading ...
Support Center